Advertisement

Topics

Amgen Sets Annual List Price for Osteoporosis Drug Evenity at $21,900

20:00 EDT 15 Apr 2019 | BioSpace

One week after the U.S. Food and Drug Administration approved Amgen’s Evenity, the California-based company has set the list price for the medication at $21,900.

Original Article: Amgen Sets Annual List Price for Osteoporosis Drug Evenity at $21,900

NEXT ARTICLE

More From BioPortfolio on "Amgen Sets Annual List Price for Osteoporosis Drug Evenity at $21,900"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...